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Rationale As a result of demographic changes with a pre-
sumed rapidly increasing number of older people during
the coming decades, a strong increase in the incidence and
prevalence of stroke should be expected. Early supported
discharge implies that the patients are discharged to their
homes as soon as feasible and that rehabilitative treatment
is offered after the discharge, with the patients being home-
dwelling. This has proved beneficial in previous studies.
Aims The main objective of this study is to further charac-
terize the important components of early supported dis-
charge and to confirm superiority of early supported
discharge over conventional treatment. The secondary aim
will be to compare two different early supported discharge
schemes. These early supported discharge schemes are com-
posed of intensive rehabilitation treatment given by a multi-
disciplinary team in a day unit and, alternatively, the same
treatment given in the patients’ homes.
Design The study is conducted as a randomized controlled
trial with three arms: two different forms of early supported
discharge and a control arm with conventional treatment.
Patients with acute stroke admitted to our hospital’s stroke
unit and living in the Municipality of Bergen are considered
for inclusion. A total of 350 stroke patients are expected.
Study outcomes Primary outcome is modified Rankin Scale
six-months after inclusion. Secondary outcomes include
Barthel Index and National Institute of Health Stroke Scale at
several points in time after inclusion, as well as many
other schemes, questionnaires and physical tests. The
study is registered in ClinicalTrials.gov registration
number NCT00771771.
Key words: clinical trial, early supported discharge, ESD, RCT,
rehabilitation, stroke
Introduction
The number of strokes in Norway is estimated to approxi-
mately 14 500 per year (1). Stroke is the third most common
cause of death in our country and the most common cause of
lasting disability (1), and it consumes a substantial part of our
health-care resources. The best possible outcome after stroke
is therefore essential, both for the individual patient and for
the society. Several studies have indicated that an early sup-
ported discharge (ESD) model for stroke patients is better
than hospital rehabilitation (2–7). A Cochrane report from
2005, evaluating the available published studies until then,
concluded that ESD was beneficial for a selected group of
stroke patients (8). A consensus document has recently been
created, with statements regarding team composition, model
of teamwork, intervention, and success (9).
However, the original Cochrane report emphasized the
need for future studies in order to clarify which elements
of ESD in the primary health care were important, and for
more precise clarification of cost–benefit in different patient
groups. A recent meta-analysis reviewed the results from 11
trials where rehabilitation was offered either centre-based or
home-based and found a significant effect in favor of home-
based rehabilitation at six-weeks and three- to six-months
(10). This question is also addressed in the present study. The
main objective of the study is to further characterize the
important components of ESD and to confirm superiority of
ESD over conventional treatment. The secondary aim will be
to compare the two different ESD schemes.
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Methods
Design
The main hypotheses are that treatment with ESD is superior
to ordinary rehabilitation in hospital and that the more precise
composition of the treatment during the first intensive phase
after discharge from hospital may be of importance. We have
therefore established two different treatment modalities where
the difference is the treatment arena: it is given either in a day
unit or in the patients’ own homes. Also, the amount and
intensity of rehabilitation and follow-up after early discharge
is important for the degree of benefit from the treatment, and
this is therefore as far as possible kept at the same level in the
two treatment modalities.
The study is conducted as a three-armed randomized
controlled trial. Patients in the study arms A and B are treated
with ESD according to the two different outpatient follow-up
schemes. Patients in arm C receive treatment after today’s
principles and they thereby constitute a control group. A sche-
matic overview of the study and patient flow is given in Fig. 1.
Patient population
All stroke patients living in Bergen admitted to the Depart-
ment of Neurology, Haukeland University Hospital, are
considered for inclusion in the study. The inclusion and exclu-
sion criteria are shown in Table 1. The inclusion period is 8
December 2008 through 20 December 2011, except for Easter,
summer, and Christmas holiday periods.
Randomization
The patients are prerandomized into three groups (A, B,
and C) by computer-generated block randomization with six
patients in each block. The consecutive patients are assigned to
their group in the same order as they are included into the
study. The randomization group is not known to the patients
nor the persons testing them at baseline, and as far as possible,
not to the testers later in the study. These testers are partly
other persons than in the acute phase testing, and the patients
are instructed not to tell their group to the testers.
Treatment/intervention
Treatment in arms A and B
The treatment is given in accordance with the ESD concept,
which in this study encompasses the following:
• The patients are discharged to their homes as early as pos-
sible and advisable. Generally, this means that the patients
should be capable of independent locomotion and to go to the
Fig. 1 Overview of study and patient flow.
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toilet without help. The more affected patients therefore may
need an inpatient rehabilitation period before discharge to
home.
• During the hospitalization and the first five-weeks after
discharge, the patients are followed and supervised by an
outpatient ambulatory coordinating team, including physi-
otherapist, occupational therapist, and nurse. This team coop-
erates closely with the municipal health care in the planning
and implementation of further rehabilitation after discharge.
The ambulatory team has a central coordinating function and
serves as a link between the patient, relatives, hospital person-
nel, and the personnel in the municipal health care. The
ambulatory team connects with the individual patients as
well as the municipal health care as soon as possible after
randomization to study arm. The team members participate
in transfers between the health-care levels, and they parti-
cipate in home visits and the later multidisciplinary out-
patient follow-ups at the Department of Physical Medicine
and Rehabilitation.
• The patients are offered treatment by a specific municipal
health-care team up to four-hours a day for up to five-weeks
after discharge from hospital. This team is composed of physi-
otherapists, occupational therapists, and a nurse trained for
stroke patients. Treatment by other professions, particularly
speech therapists, is considered if needed. It is considered
important that the municipal health-care team’s treatment
is comparable with the rehabilitation otherwise offered at
an inpatient department but remaining day-based with the
patients living in their own homes. The amount of rehabilita-
tion given in this five-week period is modified according to the
patients’ needs and recorded as treatment hours with each of
the team’s professions.
• Systematic multidisciplinary outpatient follow-ups are
offered three- and six-months after inclusion. The main inten-
tion with this follow-up is to discover the various needs that
the patients may have and then provide necessary help or
report this information to the municipal health care. In addi-
tion, lifestyle issues including physical activity are discussed
when appropriate.
Particulars for treatment arm A
These patients receive the treatment from the municipal
health-care team in a day unit.
Particulars for treatment arm B
These patients receive the treatment from the municipal
health-care team in their own homes.
Treatment in arm C (the control group)
The stroke patients in this group receive treatment after
today’s principles and routines. This encompasses acute stroke
treatment in a stroke unit, followed by transfer to the Depart-
ment of Physical Medicine and Rehabilitation, if needed,
based on a professional judgment. Other alternatives are dis-
charge directly to home or discharge to inpatient treatment in
a municipal health care institution.
Primary outcome
The primary outcome in this study is the modified Rankin
Scale (mRS) value six-months after inclusion.
Secondary outcomes
In addition, the patients included in the study will be evalu-
ated with many other predefined measuring instruments
zero-, three-, six-, 12, and 24 months after inclusion. All the
outcomes (primary and secondary) are listed in Table 2.
At baseline mRS, Barthel Index (BI) and National Institute
of Health Stroke Scale (NIHSS) are administered by stroke
neurologists or trained stroke nurses in the Stroke unit. At
three-, six-, and 12 months, the scales are administered to all
patients by one single person (physiotherapist) who was ini-
tially trained by an experienced stroke nurse. Generally,
30–45 mins are allocated to these scorings after the acute
phase, with additional information acquired from relatives
or other health workers when appropriate. MRS and BI at 24
months are scored based on telephone interview.
Table 1 Inclusion and exclusion criteria
Inclusion criteria are:
Patient must be home-dwelling and live in the Municipality of Bergen
Inclusion within one- to seven-days after symptom onset
Inclusion within six-hours to 120 h after admission to the Department of Neurology
NIHSS score at inclusion 2–26, or a two-point increase in mRS score if 0 or 1 previously
Patients must be awake and be able to agree to the participation in the study by themselves or by relatives
No age limit for inclusion.
Exclusion criteria are:
Serious psychiatric disorders
Alcohol or substance abuse
Other serious conditions of importance to the cerebral disorder and subsequent rehabilitation process
Poor knowledge of the Norwegian language before the stroke.
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Table 2 Primary and secondary outcomes
Time Registrations and questionnaires
Before or at inclusion E-stroke†, NIHSS‡
Soon after inclusion AMPS§, TIS¶, PASS**, TUG††, FAC‡‡, NRS§§, MMSE¶¶
Standardized five-meter walking test
Evaluation by speech therapist*
Seven-days after inclusion or earlier if discharged
from the stroke unit
NIHSS, mRS***, BI†††
Comorbidity questionnaires (SCQ‡‡‡, SHC§§§)
Three-months after inclusion NIHSS, mRS, BI, Patient satisfaction
AMPS, TIS, PASS, TUG, FAC, NRS
Standardized five-meter walking test
Evaluation by speech therapist*
Six-months after inclusion NIHSS, mRS, BI, patient satisfaction
AMPS, TIS, PASS, TUG, FAC, NRS
Standardized five-meter walking test
12 months after inclusion NIHSS, mRS, BI, SIS¶¶¶, RSS****, PGIC††††, SF-36‡‡‡‡ Patient satisfaction
Cognitive/neuropsychological evaluation
Evaluation by speech therapist*
24 months after inclusion mRS, BI, PGIC, SF-36
All patients included in the study are systematically evaluated at predefined points in time after inclusion and with predefined measuring instruments
as follows (*only in patients with pathological findings at the initial examination).
Function schemes: National Institute of Health Stroke Scale, Functional Ambulation Categories, modified Rankin Scale, Barthel ADL Index.
Objective tests: Assessment of Motor and Process Skills, Trunk Impairment Scale, Postural Assessment Scale for Stroke, Timed Up-and-Go, Mini-Mental
State Examination, Standardized five-meter walking test.
Other questionnaires: Numeric Rating Scale, Self-Administered Comorbidity Questionnaire, Subjective Health Complaints, Patient satisfaction, Stroke
Impact Scale, Relative Stress Scale, Patient Global Impression of Change, Short Form 36 Health Survey.
†E-stroke (Bergen NORSTROKE Registry) is a systematic registration of many different variables at admittance/inclusion and through the acute phase,
including both demographic variables and variables directly related to the patients’ stroke disease. Magnetic resonance imaging is performed on most
patients, CT scan on the others. Electrocardiography (ECG), 24-h ECG, and ultrasound examination of heart and neck vessels are included.
‡National Institute of Health Stroke Scale: a systematic assessment tool that provides a quantitative measure of stroke-related neurologic deficit; in this
study, a version with maximum score 34 is used, which evaluates motor function only on affected side.
§Assessment of Motor and Process Skills: an observational assessment that is used to measure the quality of a person’s activities of daily living (ADL)
by rating the effort, efficiency, safety, and independence of motor and process skill items while the person is doing chosen and familiar ADL tasks.
¶Trunk Impairment Scale: evaluates the patients’ level of trunk control poststroke and was originally developed for the stroke population.
**Postural Assessment Scale for Stroke: evaluates the patient’s postural control at the activity dimension of the ICF (International Classification of
Functioning, Disability and Health).
††Timed Up-and-Go: the patient is required to rise from a chair, walk three-meters, turn, walk back to the chair, and sit down; time is measured for
the whole sequence.
‡‡Functional Ambulation Categories: categorizes the patient’s walking ability in relation to six levels of physical support.
§§Numeric Rating Scale: 11 levels from 0–10, used to detect the patient’s own perception of stroke-related problems with walking, balance, coping
with ADL, safety in physical activity, pain, and fatigue.
¶¶Mini-Mental State Examination: a brief 30-point questionnaire test used to screen for cognitive impairment.
***Modified Rankin Scale: evaluates the patient’s ADL function in seven levels; levels 0–2 signify independence.
†††Barthel ADL Index: examines the patient’s ADL function using 10 variables describing ADL and mobility.
‡‡‡Self-Administered Comorbidity Questionnaire: a self-administered measure of comorbidity, also allowing the patient to note the severity of each
comorbid condition and his or her perception of its impact on function.
§§§Subjective Health Complaints: composed of 29 questions concerning severity and duration of subjective somatic and psychological complaints.
¶¶¶Stroke Impact Scale: assesses health status following stroke in eight different domains: strength, hand function, ADL/instrumental ADL, mobility,
communication, emotion, memory and thinking and participation/role function.
****Relative Stress Scale: a 15-item interviewer-administered questionnaire designed to measure the reaction to caregiving of relative carers of elderly
patients living in the community; originally developed for dementia.
††††Patient Global Impression of Change: addresses self-reported change in the severity of a patient’s illness over a particular time interval; in the
present context since start of treatment after stroke.
‡‡‡‡Short Form 36 Health Survey: a multipurpose, short-form health survey with 36 questions constructed to satisfy minimum psychometric standards
necessary for group comparisons.
Standardized five-meter walking test: the patient walks nine-meters at self-selected speed and time is taken during the middle five-meters.
Patient satisfaction: scores self-reported benefit of and satisfaction with treatment received after stroke in five levels.
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Data management
All collected data are stored in specially allocated secure areas
on the hospital’s server, with the actual data and the patients’
identity being kept apart in different server areas.
Sample size
A sample size of approximately 350 included acute stroke
patients is expected within the three-year inclusion period.
These are divided into two active treatment groups and a
control group, each of 117 patients. Based on a previous rel-
evant study of acute stroke patients (7), the expected propor-
tions of patients with mRS  2 at six-months are calculated to
57·9 % for the treatment groups and 40·2 % for the control
group. This provides a power of 74 % to demonstrate a statis-
tically significant difference between the groups for the main
outcome mRS.
Statistical analyses
Differences between and within the groups at the follow-up
time points will be tested. Number needed to treat to obtain
one more independent stroke patient in the intervention
groups vs. the control group will be calculated. Analysis of
variance (ANOVA) and analysis of covariance analyses
(ANCOVA) will be used to measure average differences
between and within the treatment groups at different points in
time. Logistic regression will be performed to estimate odds
ratio and relative risk. Intention to treat and per-protocol
analyses will be used.
In a longitudinal design treatment effect based on
measurements at several points in time will be estimated using
methods for repeated and correlated observations such as
general estimation equations to correctly estimate confidence
intervals and P-values.
Various subgroup analyses will be performed, including
analyses according to the patients’ stroke severity evaluated by
initial NIHSS score.
Health economics
Treatment cost will be calculated for each of the three treatment
arms. The three alternatives will thereafter be compared in a
cost-effectiveness analysis in order to discover differences in
cost-effectiveness between the different treatment arms (11).
Organizational studies
The project’s organizational studies are closely coupled
with the design of the study and focusing on organizational
changes. The analytical approach centers on combining
multilevel approaches with standard theoretical premises
for organizational behavior, gathered from instrumental,
strategic, and institutional theories, in order to create a frame-
work for interpreting and understanding the organizational
processes involved with the planning and implementation of
the stroke rehabilitation chain. This enables identification of
varying types of organizational barriers against change, expos-
ing limitations of the social structures involved with stroke
treatment – but also an approach to evaluate the rehabilitation
chain in organizational terms. The Uni Stein Rokkan Centre
for Social Studies will undertake this part of the study.
Study organization
The study is conducted in collaboration between Haukeland
University Hospital (Department of Physical Medicine and
Rehabilitation, Department of Neurology and the Medical
Service Department), the Municipality of Bergen and Univer-
sity of Bergen, Bergen, Norway (Department of Public Health
and Primary Health Care). University of Bergen is project
owner and research responsible institution, and Haukeland
University Hospital carries the responsibility for medical
treatment, clinical registrations, and data collection.
Discussion
ESD after stroke has been shown to be beneficial in previous
models reported from various Western countries. Why this
model works and which components that are crucial is,
however, mostly unclear. Task-specific motor training pro-
motes restorative neuroplastic changes (12). Living in a home
environment during rehabilitation may therefore be optimal
since this will promote practicing the essential tasks of daily
living.
In this study, rehabilitative treatment given at home or in
a day unit will be compared with ordinary care without use
of the principles of ESD. In addition, rehabilitation given at
home and in a day unit will be compared. This study also
differs from previous studies in the way that the participants
will be much more extensively tested at fixed points in time
during the first 24 months after stroke and with a variety of
tests including physical tests, various scoring schemes and
questionnaires.
Results from previous studies indicate that patients with
mild to moderate stroke severity benefit the most from ESD
(8). In this study, the effect of the different treatment protocols
will be evaluated in lightly, medium-, and more severely
affected stroke patients. Also, treatment cost and total societal
economic cost will be calculated for each of the treatment
protocols, thereby providing important information for future
planning of rehabilitation programs.
The study has been approved by the Western Norway
Regional Committee for Medical Research Ethics.
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